Matches in Wikidata for { <http://www.wikidata.org/entity/Q81250975> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q81250975 description "article scientifique publié en 2007" @default.
- Q81250975 description "artículu científicu espublizáu en setiembre de 2007" @default.
- Q81250975 description "scientific article published on 13 September 2007" @default.
- Q81250975 description "wetenschappelijk artikel" @default.
- Q81250975 description "наукова стаття, опублікована у вересні 2007" @default.
- Q81250975 name "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 name "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 type Item @default.
- Q81250975 label "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 label "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 prefLabel "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 prefLabel "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 P1433 Q81250975-6C8A9D5B-62F8-46AD-A363-A3FD5568BF62 @default.
- Q81250975 P1476 Q81250975-939C5AAF-37FF-48C9-89D5-9E02535D61B6 @default.
- Q81250975 P2093 Q81250975-15D981D9-C73E-4759-8BFD-BB78379868FE @default.
- Q81250975 P2093 Q81250975-2E5207F6-B351-442D-A751-C0915AAC2739 @default.
- Q81250975 P2093 Q81250975-6C69CFFD-B078-46F6-9D53-CBD800716F6E @default.
- Q81250975 P2093 Q81250975-782DE6E6-E479-4C14-B6A2-054EE1390E1E @default.
- Q81250975 P2093 Q81250975-7B780558-2360-478A-975F-C39207BF479B @default.
- Q81250975 P304 Q81250975-231DC9EE-CC9D-4E97-96C8-C4D07D1DB002 @default.
- Q81250975 P31 Q81250975-85C2CDF7-6B65-4187-A7FB-72AC58E6926B @default.
- Q81250975 P356 Q81250975-C8509C1B-1A2A-4387-A77C-39D5722F8FF3 @default.
- Q81250975 P407 Q81250975-7CDD9204-2B2C-4EB9-9E91-4FD1AE31B7C5 @default.
- Q81250975 P433 Q81250975-4424BE25-6385-4712-9826-329AB207BC11 @default.
- Q81250975 P478 Q81250975-154565A1-CB2F-47D2-BA8A-C47F6FC7AA31 @default.
- Q81250975 P577 Q81250975-94E926E7-7C0B-465D-811C-D8B5FFD3F86A @default.
- Q81250975 P698 Q81250975-488C10B1-444E-4C5B-AF00-B1F1222584B0 @default.
- Q81250975 P356 FJ.07-8873COM @default.
- Q81250975 P698 17855621 @default.
- Q81250975 P1433 Q520194 @default.
- Q81250975 P1476 "Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation" @default.
- Q81250975 P2093 "Beijia Ma" @default.
- Q81250975 P2093 "Ines Drinnenberg" @default.
- Q81250975 P2093 "Kentaro Kajiya" @default.
- Q81250975 P2093 "Michael Detmar" @default.
- Q81250975 P2093 "Reto Huggenberger" @default.
- Q81250975 P304 "530-537" @default.
- Q81250975 P31 Q13442814 @default.
- Q81250975 P356 "10.1096/FJ.07-8873COM" @default.
- Q81250975 P407 Q1860 @default.
- Q81250975 P433 "2" @default.
- Q81250975 P478 "22" @default.
- Q81250975 P577 "2007-09-13T00:00:00Z" @default.
- Q81250975 P698 "17855621" @default.